Web23 mrt. 2024 · President and Chief Executive Officer, Laura Shawver, Ph.D., will attend the Goldman Sachs Healthcare Disruption Conference in New York City and will participate in a panel discussion titled “The Cell Therapy Re-Awakening” at 2:15 p.m. ET on Tuesday, April 4, 2024. About Capstan (www.capstantx.com) Web14 sep. 2024 · With $165 million in the bank, Capstan Therapeutics launched Wednesday to combine the potency of cell therapy with the precision of genetic medicines against various difficult-to-treat diseases. Capstan’s core technology is in vivo cell engineering. By injecting lipid nanoparticles targeted to immune cells, the biotech start-up is looking to ...
Capstan Therapeutics Announces $165 Million Financing
Web14 sep. 2024 · Capstan is also pleased to announce that Laura Shawver, Ph.D., has joined the company as President and Chief Executive Officer. Dr. Shawver brings more than 20 years of experience in executive leadership positions in oncology and other serious diseases to this role, most recently serving as CEO of Silverback Therapeutics and President and … WebCapstan Therapeutics' CEO, Laura Shawver, Ph.D., talks us through the company's in vivo CAR therapies and what led to the in vivo cell engineering breakthrough that has been decades in the making. Shawver explains the promise of harnessing mRNA and targeted LNP delivery to train a patient’s body to make CAR-T cells in vivo. how to charge honda insight
Laura Shawver - Member Board of Directors - ARS …
Web22 apr. 2024 · Laura Shawver - Member Board of Directors - ARS Pharmaceuticals, Inc. LinkedIn. View Laura Shawver’s profile on … Web24 apr. 2024 · Laura Shawver didn’t quite understand cancer until she had it. By that point, in 2006, she had already been making oncology drugs for over 15 years, a dyed-in-the-wool researcher who had ... Web6 jan. 2024 · Laura Shawver is currently Chief Executive Officer at Capstan Therapeutics, Director at ARS Pharmaceuticals and Director at Bright Peak Therapeutics. At Capstan … michel borens